BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 8944338)

  • 21. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study.
    Nijsten TE; Stern RS
    J Am Acad Dermatol; 2003 Oct; 49(4):644-50. PubMed ID: 14512910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 immunoreactivity in cutaneous PUVA tumors is similar to that in other non-melanoma skin neoplasms.
    Proby CM; du Peloux Menagé H; McGregor JM; Hobbs C; Norris PG; Smith N; Hawk JL; McKee PH
    J Cutan Pathol; 1993 Oct; 20(5):435-41. PubMed ID: 8300928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PUVA therapy does not modify arsenic carcinogenesis in psoriatics.
    Angele R; Schneider B; Jung EG
    Dermatologica; 1983; 166(3):141-5. PubMed ID: 6852326
    [No Abstract]   [Full Text] [Related]  

  • 24. Cutaneous carcinoma in psoriatic patients treated with PUVA.
    Reshad H; Challoner F; Pollock DJ; Baker H
    Br J Dermatol; 1984 Mar; 110(3):299-305. PubMed ID: 6696845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PUVA treatment and skin cancer: A follow-up study.
    Lassus A; Reunala T; Idänpää-Heikkilä J; Juvakoski T; Salo O
    Acta Derm Venereol; 1981; 61(2):141-5. PubMed ID: 6165190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatments for psoriasis and the risk of malignancy.
    Patel RV; Clark LN; Lebwohl M; Weinberg JM
    J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of cutaneous carcinoma in psoriatic patients treated with PUVA.
    Eskelinen A; Halme K; Lassus A; Idänpään-Heikkilä J
    Photodermatol; 1985 Feb; 2(1):10-4. PubMed ID: 3982991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
    Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
    J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PUVA and cancer risk: the Swedish follow-up study.
    Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Johannesson A; Berne B; Ljunggren B; Andersson T; Molin L; Nylander-Lundqvist E; Emtestam L
    Br J Dermatol; 1999 Jul; 141(1):108-12. PubMed ID: 10417523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
    Stern RS; Bagheri S; Nichols K;
    J Am Acad Dermatol; 2002 Jul; 47(1):33-9. PubMed ID: 12077578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous neoplasia following PUVA therapy for psoriasis.
    McKenna KE; Patterson CC; Handley J; McGinn S; Allen G
    Br J Dermatol; 1996 Apr; 134(4):639-42. PubMed ID: 8733363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
    Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinogenicity of combined ultraviolet B radiation and psoralen plus ultraviolet A irradiation treatment of mice.
    Granstein RD; Morison WL; Kripke ML
    Photodermatol Photoimmunol Photomed; 1992-1993 Oct; 9(5):198-202. PubMed ID: 1342188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous carcinoma and PUVA lentigines in Thai patients treated with oral PUVA.
    Gritiyarangsan P; Sindhavananda J; Rungrairatanaroj P; Kullavanijaya P
    Photodermatol Photoimmunol Photomed; 1995 Aug; 11(4):174-7. PubMed ID: 8850252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic carcinogenic potential of methotrexate and PUVA in psoriasis.
    Fitzsimons CP; Long J; MacKie RM
    Lancet; 1983 Jan; 1(8318):235-6. PubMed ID: 6130262
    [No Abstract]   [Full Text] [Related]  

  • 36. [Skin cancer and psoralen plus UVA: a retrospective study of 106 patients exposed to a great number of PUVA treatments].
    Raiss M; Templier I; Beani JC
    Ann Dermatol Venereol; 2004 May; 131(5):437-43. PubMed ID: 15235530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psoriasis therapy and the risk of skin cancers.
    Mali-Gerrits MG; Gaasbeek D; Boezeman J; van de Kerkhof PC
    Clin Exp Dermatol; 1991 Mar; 16(2):85-9. PubMed ID: 2032381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy.
    Maiorino A; De Simone C; Perino F; Caldarola G; Peris K
    J Dermatolog Treat; 2016 Oct; 27(5):443-7. PubMed ID: 26822468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
    Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
    N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
    Hearn RM; Kerr AC; Rahim KF; Ferguson J; Dawe RS
    Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.